Apr 1, 2021 7:30 am EDT Eyenovia Announces Appointment of Renowned Ophthalmologist and Scientific Leader Dr. Julia Haller to its Board of Directors
Mar 23, 2021 7:30 am EDT Eyenovia and EVERSANA Announce Partnership to Support the Potential Launch and Commercialization of MydCombi™ for Mydriasis
Mar 18, 2021 8:00 am EDT Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
Mar 17, 2021 8:00 am EDT Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of its MAP™ Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasis